Trials / Unknown
UnknownNCT05718284
High Flow Nasal Cannula After Esophagectomy
High Flow Nasal Cannula Oxygen Administration Versus Standard Care After Esophagectomy for Cancer: a Randomized Controlled Trial.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- Sponsor
- Cristian Deana · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare the effect of HFNC versus standard oxygen administration after elective esophagectomy for cancer.
Conditions
- Esophageal Cancer
- Postoperative Pulmonary Atelectasis
- Postoperative Pneumonia
- Postoperative Pneumothorax
- Postoperative Infection of Incision
- Postoperative Acute Myocardial Infarction
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AIRVO2 | APPLICATION OF HIGH FLOW NASAL CANNULA OXYGEN FOR 48 HOURS AFTER ESOPHAGECTOMY |
| OTHER | STANDARD CARE | APPLICATION OF OXYGEN THROUGH STANDARD CARE FOR 48 HOURS AFTER ESOPHAGECTOMY |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2024-10-01
- Completion
- 2025-01-01
- First posted
- 2023-02-08
- Last updated
- 2023-08-01
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05718284. Inclusion in this directory is not an endorsement.